Drugs / rgp120/HIV-1MN
rgp120/HIV-1MN
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00001052 | ? → Sep 1997 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rgp120/HIV-1MN | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00001052 ↗ |
| Known as | MN recombinant soluble gp120/HIV-1 | “MN recombinant soluble gp120/HIV-1 (rsgp120/HIV-1) (Genentech)” NCT00001052 ↗ |
| Known as | rsgp120/HIV-1 | “MN recombinant soluble gp120/HIV-1 (rsgp120/HIV-1) (Genentech)” NCT00001052 ↗ |